{
    "2019-04-04": [
        [
            {
                "time": "2018-03-15",
                "original_text": "BioPharma Sale to Strengthen General Electric’s Balance Sheet",
                "features": {
                    "keywords": [
                        "BioPharma",
                        "Sale",
                        "Strengthen",
                        "Balance Sheet"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-11-20",
                "original_text": "Investors Embrace Culp’s View of a Cash Flow Rebound in 2020",
                "features": {
                    "keywords": [
                        "Investors",
                        "Embrace",
                        "Culp",
                        "Cash Flow",
                        "Rebound",
                        "2020"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}